Urinary Tract Infections in Children: Changing Trends in Etiology and Local Resistance Patterns over a Three-Year

Patrícia Sousa1, Lucinda Delgado1, Susana Correia-de-Oliveira1

  • 1Serviço de Pediatria. Hospital Senhora da Oliveira. Guimarães. Portugal.

Acta Medica Portuguesa
|February 11, 2025
PubMed

Insights

Switching to cefuroxime for pediatric urinary tract infections reduced amoxicillin-clavulanate resistance. Cefuroxime resistance remained low, indicating a successful change in empirical antibiotic therapy for common childhood infections.

Area of Science:

  • Pediatric infectious diseases
  • Antimicrobial resistance
  • Clinical microbiology

Background:

  • Urinary tract infections (UTIs) are prevalent in children.
  • Local antibiotic resistance data is vital for effective empirical treatment.
  • This study evaluated changes in UTI pathogens and resistance following a guideline update.

Purpose of the Study:

  • To review common uropathogens in pediatric UTIs.
  • To analyze local antibiotic resistance patterns.
  • To assess the impact of switching first-line empirical antibiotic regimens.

Main Methods:

  • A cross-sectional study compared pediatric UTI cases from 2019 and 2022.
  • An internal guideline recommended cefuroxime as the first-line empirical treatment from 2019 to 2022.
  • Uropathogens, antibiotic choices, and resistance patterns were compared between the two periods.

Main Results:

  • Escherichia coli was the most frequent pathogen (79.4-83.3%).
  • Cefuroxime replaced amoxicillin-clavulanate (A-C) as the primary empirical antibiotic.
  • Resistance to A-C showed a decreasing trend (33.1% to 27.4%), while cefuroxime resistance remained low (4.7% to 3.3%).

Conclusions:

  • E. coli is the dominant pathogen in pediatric UTIs.
  • The shift to cefuroxime led to a reduction in amoxicillin-clavulanate resistance.
  • Cefuroxime demonstrated sustained low resistance, supporting its use in empirical UTI treatment.
Abstract